As a final part of the project, ASKLEPIOS will bring together the knowledge acquired in the different workpackages and use the mouse model to test the efficiency of the identified molecules to improve clinical course of rabies encephalitis. Molecules will be tested either alone or in combination with or without BBB openers.
In vivo testing of (combination of) therapeutic molecules
- No events
- The world is running out of antibiotics, WHO report confirmsA report, Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched today by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.
- WHO condemns attacks on hospitals and health workers in Idlib and HamaMultiple reported attacks on health facilities and personnel today in Syria have killed and injured health workers and disrupted health services for thousands of people. WHO condemns attacks on hospitals and health workers.
- WHO launches new NCDs Progress MonitorGovernments must step up efforts to control noncommunicable diseases (NCDs) to meet globally agreed targets, including preventing the premature deaths of millions of people from these conditions, according to a new WHO report released today. Limited national progress has been made in the fight against NCDs – primarily cardiovascular and chronic respiratory diseases, cancers and […]
- The world is running out of antibiotics, WHO report confirms